000 01501 a2200445 4500
005 20250516055517.0
264 0 _c20120523
008 201205s 0 0 eng d
022 _a1568-5608
024 7 _a10.1007/s10787-011-0092-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEl-Agamy, Dina S
245 0 0 _aPrevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice.
_h[electronic resource]
260 _bInflammopharmacology
_cDec 2011
300 _a307-16 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlanine Transaminase
_xblood
650 0 4 _aAnimals
650 0 4 _aAspartate Aminotransferases
_xblood
650 0 4 _aBenzamides
650 0 4 _aBilirubin
_xblood
650 0 4 _aCurcumin
_xpharmacology
650 0 4 _aHydroxyproline
_xmetabolism
650 0 4 _aImatinib Mesylate
650 0 4 _aLiver
_xdrug effects
650 0 4 _aLiver Cirrhosis
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aResveratrol
650 0 4 _aSchistosoma mansoni
_xisolation & purification
650 0 4 _aSchistosomiasis mansoni
_xblood
650 0 4 _aSerum Albumin
_xmetabolism
650 0 4 _aStilbenes
_xpharmacology
700 1 _aShebl, Abdelhadi M
700 1 _aSaid, Shehta A
773 0 _tInflammopharmacology
_gvol. 19
_gno. 6
_gp. 307-16
856 4 0 _uhttps://doi.org/10.1007/s10787-011-0092-6
_zAvailable from publisher's website
999 _c21185055
_d21185055